Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss
Xinxia Zhu, Russell Potterfield, Kenneth A. Gruber, Emma Qingnan Zhang, Samuel Newton, Mason A. Norgard, Peter R. Levasseur, Peng Bai, Xu Chen, Qingyang Gu, Aaron J. Grossberg, Daniel L. Marks
This study shows that TCMCB07, a melanocortin-4 receptor antagonist, reduces chemotherapy-induced anorexia and weight loss in rat models.
Journal of Clinical Investigation · Nov 7, 2024Peer-reviewedCancer Biology